Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
185 hedge funds and large institutions have $2.6B invested in Inari Medical, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 70 increasing their positions, 44 reducing their positions, and 19 closing their positions.
174% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 19
59% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 44
49% more capital invested
Capital invested by funds: $1.74B → $2.6B (+$860M)
22% more funds holding
Funds holding: 152 → 185 (+33)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
17% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $13.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$146M |
| 2 |
DCP
Darsana Capital Partners
New York
|
+$108M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.1M |
| 4 |
BlackRock
New York
|
+$52.7M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$43.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
-$201M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$38.1M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$35.3M |
| 4 |
Morgan Stanley
New York
|
-$29M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
NARI Hedge Fund Activity: Q1 2021 in Review
185 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q1 2021, worth a combined $2.6B — up 49% from $1.74B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new NARI positions and 19 closed out — a net gain of 33 holders — while 70 added to existing stakes and 44 trimmed.
The largest buyer was Macquarie Group, adding an estimated $146M. The largest seller was Versant Venture Management, exiting entirely with an estimated $201M sold.
- 185 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q1 2021, up from 152 in Q4 2020.
- Funds reported $2.6B of Inari Medical, Inc. Common Stock stock for Q1 2021, up 49% quarter-over-quarter.
- 52 funds opened new Inari Medical, Inc. Common Stock positions in Q1 2021 and 19 closed out, a net change of +33 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q1 2021 was Macquarie Group, an estimated $146M added.
- The largest Inari Medical, Inc. Common Stock seller in Q1 2021 was Versant Venture Management, an estimated $201M sold.
Based on aggregated 13F filings for Q1 2021.